OOIR: Observatory of International Research

Papers

(The TQCC of Xenotransplantation is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Progressive genetic modifications of porcine cardiac xenografts extend survival to 9 months	66
Growth hormone receptor knockout to reduce the size of donor pigs for preclinical xenotransplantation studies	37
Prevention of infection in xenotransplantation: Designated pathogen‐free swine in the safety equation	36
Cold non‐ischemic heart preservation with continuous perfusion prevents early graft failure in orthotopic pig‐to‐baboon xenotransplantation	34
The final obstacle to successful pre‐clinical xenotransplantation?	33
Factors influencing attitudes toward xenotransplantation clinical trials: A report of focus group studies	26
Genetically engineered pig kidney transplantation in a brain‐dead human subject	26
Decellularized xenografts in regenerative medicine: From processing to clinical application	23
Physiological aspects of pig kidney xenotransplantation and implications for management following transplant	23
Evidence suggesting that deletion of expression of N‐glycolylneuraminic acid (Neu5Gc) in the organ‐source pig is associated with increased antibody‐mediated rejection of kidney transplants in baboons	22
Toward acellular xenogeneic heart valve prostheses: Histological and biomechanical characterization of decellularized and enzymatically deglycosylated porcine pulmonary heart valve matrices	22
Growth hormone receptor knockout: Relevance to xenotransplantation	22
The first clinical pig heart transplant: Was IVIg or pig cytomegalovirus detrimental to the outcome?	22
Recent progress and remaining hurdles toward clinical xenotransplantation	21
Expression of human CD47 in pig glomeruli prevents proteinuria and prolongs graft survival following pig‐to‐baboon xenotransplantation	21
The porcine cytomegalovirus (PCMV) will not stop xenotransplantation	19
Racial differences in attitudes to clinical pig organ Xenotransplantation	18
Xeno‐regenerative medicine: A novel concept for donor kidney fabrication	17
Bone xenotransplantation: A review of the history, orthopedic clinical literature, and a single‐center case series	17
Commentary on achievement of first life‐saving xenoheart transplant	16
Long‐term follow‐up for the microbiological safety of clinical microencapsulated neonatal porcine islet transplantation	16
Long‐term porcine islet graft survival in diabetic non‐human primates treated with clinically available immunosuppressants	15
Porcine cytomegalovirus/porcine roseolovirus (PCMV/PRV): A threat for xenotransplantation?	15
Evidence that sensitization to triple‐knockout pig cells will not be detrimental to subsequent allotransplantation	13
Humanized von Willebrand factor reduces platelet sequestration in ex vivo and in vivo xenotransplant models	13

Solid‐phase silica‐based extraction leads to underestimation of residual DNA in decellularized tissues	12
Histopathology of pig kidney grafts with/without expression of the carbohydrate Neu5Gc in immunosuppressed baboons	12
Antibody reactivity with new antigens revealed in multi‐transgenic triple knockout pigs may cause early loss of pig kidneys in baboons	12
The attitudes of religious group leaders towards xenotransplantation: A focus group study	11
Scientific and psychosocial ethical considerations for initial clinical trials of kidney xenotransplantation	11
Initial evidence that blockade of the CD40/CD154 costimulation pathway alone is sufficient as maintenance therapy in xenotransplantation	11
How the COVID‐19 pandemic may impact public support for clinical xenotransplantation in the United States?	11
Challenges and practical realities of long‐term patient follow‐up in three xeno‐islet clinical trials: The experience in pig islet xenotransplantation trials in New Zealand and Argentina	11
The problem of the “4th xenoantigen” after pig organ transplantation in non‐human primates may be overcome by expression of human “protective” proteins	11
Experimental approach to nasal septal cartilage regeneration with adipose tissue‐derived stem cells and decellularized porcine septal cartilage	10
The 2021 IXA Keith Reemtsma Lecture: Moving xenotransplantation to the clinic	10
Further information on possible animal sources for human COVID‐19	10
Solid organ xenotransplantation at the interface between research and clinical development: Regulatory aspects	10
Xenotransplantation of tannic acid‐encapsulated neonatal porcine islets decreases proinflammatory innate immune responses	10
World first pig‐to‐human cardiac xenotransplantation	10
Potential roles of mesenchymal stromal cells in islet allo‐ and xenotransplantation for type 1 diabetes mellitus	10
A perspective on the potential detrimental role of inflammation in pig orthotopic heart xenotransplantation	10
Update on possible animal sources for COVID‐19 in humans	9
Knowledge of and attitude toward xenotransplantation among medical students in China: A cross‐sectional study	9
Effects of human TFPI and CD47 expression and selectin and integrin inhibition during GalTKO.hCD46 pig lung perfusion with human blood	9
Assessment of glomerular filtration and tubular secretion in baboons with life‐supporting pig kidney grafts	9
Immunological selection and monitoring of patients undergoing pig kidney transplantation	9
Comparative study of impact of animal source on physical, structural, and biological properties of bone xenograft	8
Multipotent mesenchymal stromal cells derived from porcine exocrine pancreas improve insulin secretion from juvenile porcine islet cell clusters	8
Xenotransplantation: A historical–ethical account of viewpoints	8
Xenotransplantation of decellularized pig heart valves—Regulatory aspects in Europe	8
The first clinical trial—Kidney or heart?	8
Coagulation, inflammation, and CD46 transgene expression in neonatal porcine islet xenotransplantation	8
Attitudes of patients with renal disease on xenotransplantation: A systematic review	8
Regulatory aspects of xenotransplantation in Korea	7
Xenotransplantation of neonatal porcine bone marrow‐derived mesenchymal stem cells improves murine hind limb ischemia through lymphangiogenesis and angiogenesis	7
Xenogeneic mesenchymal stem cell transplantation for mandibular defect regeneration	7
Invited commentary: Initial reflections on the world's first clinical genetically‐engineered pig heart transplant	7
Deep anterior lamellar keratoplasty with cross‐linked acellular porcine corneal stroma to manage fungal keratitis	7
Regulatory changes in China on xenotransplantation and related products	6
The road to the first FDA‐approved genetically engineered pig heart transplantation into human	6
Xenotransplantation of neonatal porcine bone marrow–derived mesenchymal stem cells improves diabetic wound healing by promoting angiogenesis and lymphangiogenesis	6
Efficacy of ATG and Rituximab in capuchin monkeys (a New World monkey)–An in vitro study relevant to xenotransplantation	6
The case for the therapeutic use of mechanistic/mammalian target of rapamycin (mTOR) inhibitors in xenotransplantation	6
Early testing of porcine organ xenotransplantation products in humans: Microbial safety as illustrated for porcine cytomegalovirus	6
Anti‐thymoglobulin induction improves neonatal porcine xenoislet engraftment and survival	6
Upfront use of eculizumab to treat early acute antibody‐mediated rejection after kidney allotransplantation and relevance for xenotransplantation	6
Pig‐to‐human kidney transplantation using brain‐dead donors as recipients: One giant leap, or only one small step for transplantkind?	6
PCR and peptide based PCMV detection in pig – development and application of a combined testing procedure differentiating newly from latent infected pigs	6
The human T‐cell proliferative response to triple‐knockout pig cells in mixed lymphocyte reaction	6
Partnership of the International Xenotransplantation Association, The Transplantation Society, and World Health Organization in the development of guidance documents and policies for xenotransplantati	6